Other
Neoplasm by Morphology
CI-CAN-00000002Explore in graph →
Non-malignant13,325 active trials222 approved drugs2,774 evidence items
- NCIt
- C4741
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000002Explore in graph →
Clinical trials
52,671 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00280618 | Oxaliplatin in Unresectable Hepatocellular Carcinoma | completed | Phase 2 | — | SanofiINDUSTRY | 0 | Sep 15, 2009 | clinicaltrials |
| NCT00581698 | Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan Blue | completed | — | 876 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00931190 |
| Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia |
| completed |
| — |
| 195 |
| Lund UniversityOTHER |
| 1 |
| Sep 15, 2009 |
| clinicaltrials |
| NCT00530699 | Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML) | completed | Phase 1 | 30 | AstraZenecaINDUSTRY | 1 | Sep 11, 2009 | clinicaltrials |
| NCT00173836 | Swallowing Pattern of Patients With Nasopharyngeal Cancer Before and After Radiation Therapy: Longitudinal Study and Correction With Saliva Amount | completed | — | 122 | National Taiwan University HospitalOTHER | 1 | Sep 9, 2009 | clinicaltrials |
| NCT00970385 | Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma(LTP) | completed | Phase 3 | 95 | University Hospital, GrenobleOTHER | 1 | Sep 9, 2009 | clinicaltrials |
| NCT00147875 | Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma | completed | Phase 1 / Phase 2 | 60 | University of CologneOTHER | 1 | Sep 7, 2009 | clinicaltrials |
| NCT00630240 | Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization | completed | — | 53 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Sep 1, 2009 | clinicaltrials |
| NCT00965627 | Biology of Thymic Tumors | completed | — | 134 | Istituto Clinico HumanitasOTHER | 1 | Aug 28, 2009 | clinicaltrials |
| NCT00965289 | High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma | completed | Phase 2 | 42 | Nantes University HospitalOTHER | 1 | Aug 26, 2009 | clinicaltrials |
| NCT00186316 | Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells | completed | Phase 1 / Phase 2 | 30 | Stanford UniversityOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00625768 | Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma | completed | Phase 1 | 13 | Antisoma ResearchINDUSTRY | 2 | Aug 25, 2009 | clinicaltrials |
| NCT00037583 | Study Evaluating the Safety and Efficacy of Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia | completed | Phase 2 | 69 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Aug 21, 2009 | clinicaltrials |
| NCT00063219 | Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy | completed | Phase 2 | 48 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Aug 21, 2009 | clinicaltrials |
| NCT00067548 | Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 44 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Aug 21, 2009 | clinicaltrials |
| NCT00962767 | Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission | completed | Phase 3 | 168 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Aug 20, 2009 | clinicaltrials |
| NCT00373373 | Efficacy of Sorafenib Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML | completed | Phase 2 | 200 | University Hospital MuensterOTHER | 1 | Aug 19, 2009 | clinicaltrials |
| NCT00495846 | GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma(SS-HCC) | completed | Phase 2 / Phase 3 | 25 | Federico II UniversityOTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00327249 | Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients | completed | Phase 1 / Phase 2 | — | AmpliMed CorporationINDUSTRY | 1 | Aug 11, 2009 | clinicaltrials |
| NCT00955786 | Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 48 | Cylene PharmaceuticalsINDUSTRY | 1 | Aug 10, 2009 | clinicaltrials |
| NCT00418327 | Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma | completed | Phase 1 | 48 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Aug 7, 2009 | clinicaltrials |
| NCT00306813 | Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma | completed | Phase 1 / Phase 2 | 53 | University of WuerzburgOTHER | 1 | Aug 4, 2009 | clinicaltrials |
| NCT00769730 | Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication | completed | — | 25 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Aug 4, 2009 | clinicaltrials |
| NCT00264498 | Phase II Iressa & Carbo/Gem in NSCLC | completed | Phase 2 | 38 | AstraZenecaINDUSTRY | 1 | Aug 3, 2009 | clinicaltrials |
| NCT00382759 | Nonmyeloablative Stem Cell Transplant in Elderly | completed | Phase 2 / Phase 3 | 50 | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Aug 3, 2009 | clinicaltrials |
| NCT00950768 | Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients | completed | Phase 3 | 298 | Azienda Ospedaliera San Giovanni BattistaOTHER | 0 | Aug 3, 2009 | clinicaltrials |
| NCT00304447 | Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia | completed | Phase 4 | 30 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Jul 29, 2009 | clinicaltrials |
| NCT00945568 | Preoperative Oral Supplementation With Branched-Chain Amino Acids (BCAA) Improves Postoperative Quality of Life(KMS) | completed | N/A | 100 | Kochi UniversityOTHER | 1 | Jul 24, 2009 | clinicaltrials |
| NCT00944801 | Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma | completed | Phase 1 / Phase 2 | 63 | University of RegensburgOTHER | 1 | Jul 23, 2009 | clinicaltrials |
| NCT00165334 | Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer | completed | Phase 2 | 53 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 22, 2009 | clinicaltrials |
| NCT00210327 | VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy | completed | Phase 2 | 33 | International Extranodal Lymphoma Study Group (IELSG)OTHER | 1 | Jul 22, 2009 | clinicaltrials |
| NCT00210379 | Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma | completed | Phase 2 | 64 | International Extranodal Lymphoma Study Group (IELSG)OTHER | 1 | Jul 22, 2009 | clinicaltrials |
| NCT00613652 | A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients | completed | Phase 1 | 30 | AstraZenecaINDUSTRY | 1 | Jul 21, 2009 | clinicaltrials |
| NCT00117897 | Treatment for Subjects With Non-Hodgkin's Lymphoma | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Jul 20, 2009 | clinicaltrials |
| NCT00759837 | Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects | completed | Phase 1 | 27 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Jul 16, 2009 | clinicaltrials |
| NCT00350753 | Avastin and Tarceva for Upper Gastrointestinal Cancers | completed | Phase 2 | 126 | Rigshospitalet, DenmarkOTHER | 1 | Jul 15, 2009 | clinicaltrials |
| NCT00107861 | Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases | completed | Phase 1 / Phase 2 | 44 | BiogenINDUSTRY | 1 | Jul 14, 2009 | clinicaltrials |
| NCT00345189 | Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors | completed | Phase 1 | 70 | BiogenINDUSTRY | 2 | Jul 14, 2009 | clinicaltrials |
| NCT00444704 | Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese Females | completed | Phase 1 | — | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Jul 10, 2009 | clinicaltrials |
| NCT00911443 | Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma | completed | Phase 2 | 488 | sigma-tau i.f.r. S.p.A.INDUSTRY | 8 | Jul 9, 2009 | clinicaltrials |
| NCT00436059 | The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer) | completed | Phase 2 | 20 | Vejle HospitalOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00495924 | Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma | completed | — | 100 | KU LeuvenOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00464919 | Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 50 | National Taiwan University HospitalOTHER | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00644254 | The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic Adenocarcinoma(ECLNI DPAC) | completed | — | 145 | KU LeuvenOTHER | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00931138 | Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2(ALFA 9801) | completed | Phase 3 | 420 | Acute Leukemia French AssociationOTHER | 1 | Jul 2, 2009 | clinicaltrials |
| NCT00181506 | HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy | completed | Phase 1 / Phase 2 | 180 | Maastricht Radiation OncologyOTHER | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00181532 | Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC | completed | Phase 2 | 102 | Maastricht Radiation OncologyOTHER | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00181545 | Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients. | completed | Phase 1 | 30 | Maastricht Radiation OncologyOTHER | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00044538 | Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients | completed | Phase 2 | 102 | BayerINDUSTRY | 6 | Jun 22, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Sep 15, 2009source: clinicaltrials